AstraZeneca Rings NYSE Bell, Eyes $80B Revenue Ambition
WILMINGTON, DE — AstraZeneca began trading its ordinary shares on the New York Stock Exchange on Monday, February 2, 2026, marking a significant milestone as the global biopharmaceutical giant expands …
AstraZeneca Rings NYSE Bell, Eyes $80B Revenue Ambition Read More